Welcome to LookChem.com Sign In|Join Free

CAS

  • or

91444-18-7

Post Buying Request

91444-18-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

91444-18-7 Usage

Description

2-(4-METHOXYPHENYL)-3-METHYL-5-METHOXYINDOLE, also known as 5-Methoxy-2-(p-methoxyphenyl)skatole, is an organic compound that serves as a reactant in the synthesis of a metabolite of Bazedoxifene (B129250), a nonsteroidal selective estrogen receptor modulator (SERM). It is characterized by its indole structure with methoxy and methyl substituents, which contribute to its chemical properties and potential applications.

Uses

Used in Pharmaceutical Industry:
2-(4-METHOXYPHENYL)-3-METHYL-5-METHOXYINDOLE is used as a reactant in the synthesis of Bazedoxifene metabolites for the development of pharmaceuticals.
It plays a crucial role in the production of Bazedoxifene Acetate, which is used as an antiosteoporotic agent, helping to prevent bone loss and maintain bone density in patients suffering from osteoporosis.

Check Digit Verification of cas no

The CAS Registry Mumber 91444-18-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,4,4 and 4 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 91444-18:
(7*9)+(6*1)+(5*4)+(4*4)+(3*4)+(2*1)+(1*8)=127
127 % 10 = 7
So 91444-18-7 is a valid CAS Registry Number.

91444-18-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Methoxy-2-(4-methoxyphenyl)-3-methyl-1H-indole

1.2 Other means of identification

Product number -
Other names 3-methyl-5-methoxy-2-(4-methoxyphenyl)indole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:91444-18-7 SDS

91444-18-7Relevant articles and documents

ESTROGEN RECEPTOR TARGETING ANTAGONISTS

-

Paragraph 0031; 0106-0108, (2020/05/07)

The present disclosure relates to compounds that act as antagonists via binding to the ER ligand binding domain non-covalently or covalently, or act as both antagonists and ER protein degraders, and the synthesis of the same. Further, the present disclosure teaches the utilization of such compounds in a treatment for proliferative diseases, including cancer, particularly breast cancer, and especially ER+ breast cancer.

METHODS OF PREPARING BAZOEDOXIFENE

-

Paragraph 0095-0100, (2018/10/16)

The present invention relates to novel bazedoxifene or to a method for producing a pharmaceutically acceptable salt thereof. The production method according to the present invention can provide the bazedoxifene with high purity and high yield, and is economical and environmentally friendly in terms of time and cost due to a relatively simple manufacturing process to be usefully applied to mass production.COPYRIGHT KIPO 2018

Synthesis, antiproliferative and pro-apoptotic activity of 2-phenylindoles

Kelly, Patrick M.,Bright, Sandra A.,Fayne, Darren,Pollock, Jade K.,Zisterer, Daniela M.,Williams, D. Clive,Meegan, Mary J.

, p. 4075 - 4099 (2016/08/23)

Breast cancer is the second most common cancer worldwide after lung cancer with the vast majority of early stage breast cancers being hormone-dependent. One of the major therapeutic advances in the clinical treatment of breast cancer has been the introduction of selective estrogen receptor modulators (SERMs). We describe the design and synthesis of novel SERM type ligands based on the 2-arylindole scaffold to selectively target the estrogen receptor in hormone dependent breast cancers. Some of these novel compounds are designed as bisindole type structures, while others are conjugated to a cytotoxic agent based on combretastatin A4 (CA4) which is a potent inhibitor of tubulin polymerisation. The indole compounds synthesised within this project such as 31 and 86 demonstrate estrogen receptor (ER) binding and strong antiproliferative activity in the ER positive MCF-7 breast cancer cell line with IC50values of 2.71?μM and 1.86?μM respectively. These active compounds induce apoptotic activity in MCF-7 cells with minimal effects on normal peripheral blood cells. Their strong anti-cancer effect is likely mediated by the presence of two ER binding ligands for 31 and an ER binding ligand combined with a cytotoxic agent for 86.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 91444-18-7